Opendata, web and dolomites

ImmunoCode SIGNED

Digital Single Cell Immunology: Decoding Cellular Interactions for Improved Immunotherapy

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 ImmunoCode project word cloud

Explore the words cloud of the ImmunoCode project. It provides you a very rough idea of what is the project "ImmunoCode" about.

longitudinally    vaccine    metastatic    cellular    remarkably    pathogen    vaccines    tight    patients    multitude    roles    ultimately    omission    battle    inducing    shows    external    revolutionise    prime    technologies    plasticity    exploited    platform    swiss    secrete    diseases    regulate    pdc    strategies    amounts    unravel    ctls    erc    cell    augmented    cells    heterogeneous    superior    infectious    elusive    cancer    functional    innovative    influence    knives    possess    pdcs    minimal    immunocode    microfluidic    immune    differently    auto    decoding    cytotoxic    anti    act    environments    heterogeneity    function    successful    vaccination    interactions    massive    despite    pairs    tumour    exert    tolerance    me    population    populations    immunology    risk    rare    poorly    opportunity    immunotherapy    functions    dendritic    tremendous    transcriptomics    army    ifns    human    refining    specialized    effector    extremely    plasmacytoid    induce    fact    small    single    balance    immunity    subset   

Project "ImmunoCode" data sheet

The following table provides information about the project.

Coordinator
TECHNISCHE UNIVERSITEIT EINDHOVEN 

Organization address
address: GROENE LOPER 3
city: EINDHOVEN
postcode: 5612 AE
website: www.tue.nl/en

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Netherlands [NL]
 Total cost 1˙812˙143 €
 EC max contribution 1˙812˙143 € (100%)
 Programme 1. H2020-EU.1.1. (EXCELLENT SCIENCE - European Research Council (ERC))
 Code Call ERC-2018-STG
 Funding Scheme ERC-STG
 Starting year 2018
 Duration (year-month-day) from 2018-11-01   to  2023-10-31

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    TECHNISCHE UNIVERSITEIT EINDHOVEN NL (EINDHOVEN) coordinator 1˙812˙143.00

Map

 Project objective

Successful immunotherapy against cancer is the result of a multitude of cellular interactions within the immune system. It is highly exciting how vaccination with small numbers of human plasmacytoid dendritic cells (pDCs) can induce anti-tumour immunity in metastatic cancer patients. Remarkably, how pDCs, as an extremely rare subset of cells, can act as Swiss army knives to regulate the tight balance between tolerance and immunity: i.e. secrete massive amounts of type I IFNs, prime T cells and exert cytotoxic effector functions, is still elusive. Do pDCs possess all functions or comprises the population distinct functional subsets all with their specialized roles. I will unravel which pDC is superior in inducing cytotoxic T cells (CTLs) for augmented cancer immunity. Despite advances in single cell technologies, understanding the role of heterogeneity in immune cell populations, remains poorly understood. In ImmunoCode, I will develop a novel and ambitious single cell technology platform, wherein innovative microfluidic approaches and single cell transcriptomics allow 1) functional analysis of single (pairs of) immune cells and 2) design of minimal environments under the omission of external factors that could influence cellular behaviour. This approach will provide me with the unique opportunity to unravel pDC function and plasticity. Although in this ERC proposal I will focus on understanding pDCs heterogeneity, my technology can in fact be exploited to any cell type that shows heterogeneous function. My unique and high-risk technical approach allows for decoding immune cell-cell or cell-pathogen interactions longitudinally and in great detail which will revolutionise the fields of immunology and cellular immunotherapy. Ultimately, ImmunoCode will have a tremendous impact by refining the design of vaccine strategies and the development of differently composed cellular vaccines to battle cancer and infectious and auto-immune diseases.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "IMMUNOCODE" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "IMMUNOCODE" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.1.1.)

MOCHA (2019)

Understanding and leveraging ‘moments of change’ for pro-environmental behaviour shifts

Read More  

ZARAH (2020)

Women’s labour activism in Eastern Europe and transnationally, from the age of empires to the late 20th century

Read More  

ChaperoneRegulome (2020)

ChaperoneRegulome: Understanding cell-type-specificity of chaperone regulation

Read More